Eurizon Capital SGR S.p.A. acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 33,333 shares of the semiconductor company's stock, valued at approximately $15,662,000.
Several other large investors also recently modified their holdings of the stock. Fideuram Asset Management Ireland dac acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $571,000. National Pension Service grew its position in shares of Synopsys by 5.2% during the 4th quarter. National Pension Service now owns 450,010 shares of the semiconductor company's stock worth $211,379,000 after buying an additional 22,393 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $551,000. SBI Okasan Asset Management Co.Ltd. acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $1,699,000. Finally, Jupiter Asset Management Ltd. grew its position in shares of Synopsys by 18.5% during the 4th quarter. Jupiter Asset Management Ltd. now owns 45,194 shares of the semiconductor company's stock worth $21,229,000 after buying an additional 7,042 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.
Synopsys Stock Performance
Shares of Synopsys stock opened at $475.62 on Monday. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The stock's 50-day simple moving average is $459.53 and its 200 day simple moving average is $454.83. The stock has a market capitalization of $91.07 billion, a P/E ratio of 110.10, a P/E/G ratio of 3.75 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the prior year, the firm posted $3.67 earnings per share. The company's revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, research analysts anticipate that Synopsys, Inc. will post 10.28 EPS for the current year.
Synopsys News Summary
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys said demand for AI chip design software is driving stronger business momentum, and it raised its annual forecast as a result. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: The CFO highlighted that AI companies are increasingly using custom computer designs, a trend that could expand demand for Synopsys’ chip-design tools. AI Computer Design Diversity A Boon For Synopsys, Says CFO
- Positive Sentiment: Analysts raised price targets after the earnings report, signaling confidence in Synopsys’ longer-term growth outlook despite the stock’s recent weakness. Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Positive Sentiment: Synopsys also showcased new AI and multi-die design capabilities with Samsung Foundry, underscoring its role in advanced chip development. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
- Neutral Sentiment: The company beat fiscal Q2 estimates, with revenue up 41.9% year over year and EPS above expectations, but the market still sold the stock after the report. Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus
- Negative Sentiment: Investors appear wary about the company’s chip-IP business and the broader impact of integrating Ansys, which may be weighing on sentiment even after strong results. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
Analyst Ratings Changes
Several analysts recently issued reports on the stock. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a research report on Tuesday, May 26th. Citigroup lifted their price target on shares of Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday. Berenberg Bank set a $633.00 price target on shares of Synopsys in a research report on Wednesday. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday. Finally, KeyCorp reaffirmed an "overweight" rating on shares of Synopsys in a report on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Synopsys presently has a consensus rating of "Hold" and an average price target of $563.81.
View Our Latest Research Report on Synopsys
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.